<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html lang="en" xml:lang="en" xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/>
<title>Ministry of Health &amp; Welfare : ABOUT MOHW &gt; Press Release View Content</title>
<link href="../../css/eng/mwf_eng.css" rel="stylesheet" type="text/css"/>
<script src="../../js/jquery-1.11.0.min.js" type="text/javascript"></script>
<script src="../../js/common.js" type="text/javascript"></script>
<script src="../../js/mw_eng.js" type="text/javascript"></script>
<script type="text/javascript">

//<![CDATA[



	// ¸®½ºÆ®·Î ÀÌµ¿

	function jsList()

	{

		var form = document.fmList;

		form.action = "ssg0111ls.jsp";

		form.submit();

	}



	//³»¿ë º¸±â

	function goView(seq)

	{

		var form = document.fmView;

		form.CONT_SEQ.value = seq;

		form.action = "ssg0111vw.jsp";

		form.submit();

	}



	//ÇÏ´Ü ¸®½ºÆ® ÆäÀÌÁö ÀÌµ¿

	function goPage( page)

	{

		var form = document.fmList;

		form.page.value = page;

		form.submit();

	}



	//ÆÄÀÏ ´Ù¿î·Îµå.

	function fileDownLoad(fileSeq)

	{

		if( confirm( "Do you wish to download now?") == true ) {

			var form = document.fmView;

			form.FILE_SEQ.value = fileSeq;

			form.action = "/front_new/modules/download.jsp";

			form.submit();

		}

	}

//]]>

</script>
</head>
<body>
<!-- ¹Ù·Î°¡±â ¸µÅ© -->
<p id="skip-navi">
<a href="#contents">go to the contents</a>
<a href="#snb">go to the menu</a>
</p>
<!-- //¹Ù·Î°¡±â ¸µÅ© -->
<!-- header -->
<div id="wrap">
<!-- head -->
<div class="sbHead" id="head">
<!-- header -->
<div id="header">
<!-- ·Î°í -->
<h1 class="logo"><a href="../261f58801c1da21d0b6f7021b30b648b"><img alt="ministry of health and welfare" src="../../images/eng/common/logo.gif"/></a></h1>
<div class="kor_sym">
<a href="../../../moi.go.kr/eng/sub/a03/nationalSymbol/d5a2e22490af7d4414516807b47a6064" target="_blank" title="new browser"><img alt="National Symbols of the Republic of Korea" src="../../images/eng/common/kor_sym_eng.gif"/></a>
</div>
<!-- function -->
<div class="function">
<!-- [Funciton] - ÆùÆ®»çÀÌÁî -->
<div class="unit">
<div class="ft_size">
<button class="plus" onclick="fontSizeWrap.btnPlus();" type="button"><span class="hide">expand</span></button>
<button class="minus" onclick="fontSizeWrap.btnMinus();" type="button"><span class="hide">reduce</span></button>
<span class="Font_Size"><span class="hide">Font Size</span></span>
</div>
<script type="text/javascript">var fontSizeWrap = new fontSize();</script>
<!-- //[Funciton] - ÆùÆ®»çÀÌÁî -->
<!-- ¾ð¾îº° ¸µÅ© -->
<ul class="global_language">
<li class="mobile"><a href="../../m_eng/50b06ecdc2a14f90913d780c3460fca4" target="_blank" title="new browser"><span class="hide">Mobile</span></a></li>
<li class="Korean"><a href="../../front_new/647a6a76a15a5a8bfc6d5f73d0d9d4d1" target="_blank" title="new browser"><span class="hide">Korean</span></a></li>
<li class="sitemap"><a href="../cs/38f03257ef34df8e601ed2e794b4f84f"><span class="hide">sitemap</span></a></li>
<li class="a-z"><a href="../cs/1001c96bb6754f09ed925f7b6d593bf7"><span class="hide">A-Z Index</span></a></li>
</ul>
<!-- //¾ð¾îº° ¸µÅ© -->
<!-- ¸Þ´º¼³Á¤ -->
<div class="mnsetup">
<div class="btnsetup"><a class="btnms" href="#msetup_layer" id="svcmore_h"><span class="hide">my menu</span></a></div>
<div class="msetup_layer" id="msetup_layer">
<h2>
<img alt="Menu setup" src="../../images/eng/main/musetup.gif"/>
</h2>
<div class="mnsetup_cont">
<ul class="list" id="fmenu"><li>My menu list</li></ul>
</div>
<div class="cg_contwrap">
<div class="cg_cont">
<!-- ÀüÃ¼¸ñ·Ï -->
<ul class="ms_category">
<li>
<input class="input-check" id="mw_100103" name="setmenu" type="checkbox" value="/eng/sg/ssg0103mn.jsp?PAR_MENU_ID=1001&amp;MENU_ID=100103|100103|Organization"/>
<label for="mw_100103">Organization</label>
</li>
<li>
<input class="input-check" id="mw_100113" name="setmenu" type="checkbox" value="/eng/sg/ssg0101mn.jsp?PAR_MENU_ID=1001&amp;MENU_ID=100113|100113|Contact Us"/>
<label for="mw_100113">Contact Us</label>
</li>
<li>
<input class="input-check" id="mw_100105" name="setmenu" type="checkbox" value="/eng/sg/ssg0105mn.jsp?PAR_MENU_ID=1001&amp;MENU_ID=100105|100105|Minister's Profile"/>
<label for="mw_100105">Minister's Profile</label>
</li>
<li>
<input class="input-check" id="mw_100111" name="setmenu" type="checkbox" value="/eng/sg/ssg0111ls.jsp?PAR_MENU_ID=1001&amp;MENU_ID=100111|100111|Press Release"/>
<label for="mw_100111">Press Release</label>
</li>
<li>
<input class="input-check" id="mw_10031801" name="setmenu" type="checkbox" value="/eng/jc/sjc0101mn.jsp?PAR_MENU_ID=1003&amp;MENU_ID=10031801|10031801|Policies"/>
<label for="mw_10031801">Policies</label>
</li>
<li>
<input class="input-check" id="mw_100408" name="setmenu" type="checkbox" value="/eng/cs/scs0301mn.jsp?PAR_MENU_ID=1004&amp;MENU_ID=100408|100408|RSS"/>
<label for="mw_100408">RSS</label>
</li>
<li>
<input class="input-check" id="mw_100410" name="setmenu" type="checkbox" value="/eng/cs/scs0301mn.jsp?PAR_MENU_ID=1004&amp;MENU_ID=100410|100410|Privacy Guideline"/>
<label for="mw_100410">Privacy Guideline</label>
</li>
<li>
<input class="input-check" id="mw_100404" name="setmenu" type="checkbox" value="/eng/cs/scs0301mn.jsp?PAR_MENU_ID=1004&amp;MENU_ID=100404|100404|Users Guide"/>
<label for="mw_100404">Users Guide</label>
</li>
</ul>
<!-- //ÀüÃ¼¸ñ·Ï -->
</div>
<!-- ¹öÆ° Á¤·Ä -->
<div class="btn_msetup">
<p class="left"><input alt="default" class="input-image" id="mymenu_default" src="/images/eng/btn/btn_base.gif" type="image"/></p>
<span class="cg_msg">User can personalize the website</span>
<p class="center">
<input alt="confirm" class="input-image" id="mymenu_set" src="/images/eng/btn/btn_confirm.gif" type="image"/>
<!--a href="#" id="mymenu_set" ><img src="/images/front/btn/btn_confirm.gif" alt="È®ÀÎ" /></a-->
<input alt="cancel" class="input-image" id="mymenu_cancel" src="/images/eng/btn/btn_cancel.gif" type="image"/>
</p>
<p class="right"><a href="../cs/38f03257ef34df8e601ed2e794b4f84f">sitemap</a></p>
</div>
<!-- //¹öÆ° Á¤·Ä -->
</div>
<p class="btn-more"><button class="msbtn_close" id="msbtn_close" type="button"><span class="hide">close</span></button></p>
</div>
</div>
<!-- //¸Þ´º¼³Á¤ -->
<!-- °Ë»ö -->
<!-- 

					<div class="search">

						<form method="post" name="fmSearch" action="/eng/cs/scs0401ls.jsp" onsubmit="return searchCommon(this)" >

							<input type="hidden" name="PAR_MENU_ID" value="1004" />

							<input type="hidden" name="MENU_ID" value="100406" />

							<input type="hidden" name="SEARCHKEY" value="TITLE" />				

							<fieldset>

								<legend>search</legend>

								<label for="SEARCHVALUE" class="hide">search value</label>

								<input type="text" id="SEARCHVALUE" name="SEARCHVALUE" class="input-text" />

								<input type="image" class="input-image" src="/images/eng/common/tl_btnsearch.gif" alt="search" />

							</fieldset>

						</form>

					</div>

					 -->
<!-- //°Ë»ö -->
</div><!-- //unit -->
</div>
<!-- //function -->
</div>
<!-- //header -->
</div>
<!-- //head -->
<hr/>
<!-- spot main -->
<div id="spot-sub">
<img alt="A life-long friend who stands by the public" src="../../images/front_eng/sg/img_head_sg.jpg"/>
</div>
<!-- //spot main -->
<hr/>
<!-- container -->
<div class="clear" id="container">
<div id="subwrap">
<!-- snb -->
<div id="snb">
<h2><a href="616feca8de871f8a1f1e040342b5d550"><img alt="About MW" src="../../images/front_eng/title/h2_am.gif"/></a></h2>
<ul id="snbMenu1">
<li><a href="616feca8de871f8a1f1e040342b5d550"><img alt="Vision &amp; Mission" src="../../images/front_eng/title/left_am01.gif"/></a>
</li>
<li><a href="93dae7d73a99735630654fc2fb46a9eb"><img alt="Organization" src="../../images/front_eng/title/left_am02.gif"/></a>
</li>
<li><a href="482124899dc6a43227599ea28a921fea"><img alt="Contact Us" src="../../images/front_eng/title/left_am03.gif"/></a>
</li>
<li><a href="2d75b746f82cbae41316bd3da4ceb30d"><img alt="Minister¡¯s Profile" src="../../images/front_eng/title/left_am04.gif"/></a>
</li>
<li><a href="a2fde158a68020769e116fe2815d95aa"><img alt="Vice Minister¡¯s Profile" src="../../images/front_eng/title/left_am05.gif"/></a>
</li>
<li><a href="8c6914a853d28a0cf2ce417c6d5fe3ce"><img alt="Past Ministers &amp; Vice Ministers" src="../../images/front_eng/title/left_am06.gif"/></a>
</li>
<li><a href="a79fdae6ffae612a0b5f784645afb1db"><img alt="Location" src="../../images/front_eng/title/left_am07.gif"/></a>
</li>
<li class="on"><a href="76b19fd6a92fcb216e55a4e9dea9a4c8"><img alt="Press Release" src="../../images/front_eng/title/left_am08_over.gif"/></a>
</li>
<li><a href="ea8a1ea6f8dcdcb2b03b8ebc89df5ef6"><img alt="129 Call Center" src="../../images/front_eng/title/left_am09.gif"/></a>
</li>
<li><a href="../../../www.epeople.go.kr/jsp/user/on/eng/ebb342dee28c17242d927d0b1019800f" target="_blank"><img alt="Online Petition" src="../../images/front_eng/title/left_am10.gif"/></a>
</li>
</ul>
<h2><a href="../jc/f397eab66fb162470b191bcc18dfac4f"><img alt="Policies" src="../../images/front_eng/title/h2_pl.gif"/></a></h2>
<ul id="snbMenu2">
<li class="submenu"><img alt="Enhancement of Customized Welfare Services by Life-Cycle Phase" src="../../images/front_new/title/left_pl100321.gif"/>
<ul>
<li><a href="../jc/f397eab66fb162470b191bcc18dfac4f"><img alt="Reinforcement of support for income growth and work opportunities of low-income people" src="../../images/front_new/title/left_pl10032101.gif"/></a></li>
<li><a href="../jc/6d963af417c35f2c3575a2f47d93315d"><img alt="Welfare services reaching out to people and improvement of public perception" src="../../images/front_new/title/left_pl10032102.gif"/></a></li>
<li><a href="../jc/7c117d987132de318dd869c7e15cd6d1"><img alt="Promotion of rights and interests of children, the disabled, the elderly, etc." src="../../images/front_new/title/left_pl10032103.gif"/></a></li>
<li><a href="../jc/3cd7dc5b01d534d90eba055e35cdf386"><img alt="Reduction of burden of medical expenses, and the reorganization of the system for determining health insurance premiums" src="../../images/front_new/title/left_pl10032104.gif"/></a></li>
</ul>
</li>
<li class="submenu"><img alt="Establishment of Health Insurance System centered on People" src="../../images/front_new/title/left_pl100322.gif"/>
<ul>
<li><a href="../jc/6698fa46cb8d35f0f8aeb6f289ab2ce9"><img alt="Reinforcement of patient-oriented medical services" src="../../images/front_new/title/left_pl10032201.gif"/></a></li>
<li><a href="../jc/6194a5e0555dab84754814c541f09b27"><img alt="Strengthening of essential and public health care services and systematic response to infectious diseases" src="../../images/front_new/title/left_pl10032202.gif"/></a></li>
<li><a href="../jc/7603054a50c83c708da6d6702afe3d14"><img alt="Reinforcement of Preventive Health Care" src="../../images/front_new/title/left_pl10032203.gif"/></a></li>
<li><a href="../jc/5975190b9def38149afd3ad48132162f"><img alt="Enhancement of healthcare industry performance and job creation" src="../../images/front_new/title/left_pl10032204.gif"/></a></li>
</ul>
</li>
<li class="submenu"><img alt="Strengthening Responses to Demographic Crisis" src="../../images/front_new/title/left_pl100323.gif"/>
<ul>
<li><a href="../jc/8334fe91b7312eb840b99581e90bc297"><img alt="Establishment of a response system for coping with low birthrate" src="../../images/front_new/title/left_pl10032301.gif"/></a></li>
<li><a href="../jc/687f9bcd11741aea5264c8392dc17ffc"><img alt="Improvement of a system for supporting childbirth and parenting" src="../../images/front_new/title/left_pl10032302.gif"/></a></li>
<li><a href="../jc/d59e41ec8156d3ed1193b5f64629cf85"><img alt="Enhancement of preparation for aging society" src="../../images/front_new/title/left_pl10032303.gif"/></a></li>
</ul>
</li>
</ul>
<h2><a href="../cs/b64cc4894874ba0eb4af154d245908a9"><img alt="Help" src="../../images/front_eng/title/h2_hp.gif"/></a></h2>
<ul id="snbMenu3">
<li><a href="../cs/b64cc4894874ba0eb4af154d245908a9"><img alt="Users Guide" src="../../images/front_eng/title/left_hp01.gif"/></a>
</li>
<li><a href="../cs/81e6dbd0ed113665170a29b899ab0c21"><img alt="Privacy Guideline" src="../../images/front_eng/title/left_hp04.gif"/></a>
</li>
<li><a href="../cs/bab2f9d80d5980695b6081cb22ceb64b"><img alt="RSS" src="../../images/front_eng/title/left_hp03.gif"/></a>
</li>
<li><a href="../cs/38f03257ef34df8e601ed2e794b4f84f"><img alt="Sitemap" src="../../images/front_eng/title/left_hp05.gif"/></a>
</li>
<li><a href="../cs/1001c96bb6754f09ed925f7b6d593bf7"><img alt="A-Z Index" src="../../images/front_eng/title/left_hp06.gif"/></a>
</li>
</ul>
</div>
<script src="../../js/jquery-1.11.0.min.js" type="text/javascript"></script>
<script type="text/javascript">
			$('.submenu').last().find('ul').attr('class', 'noline');
			imgMenuOver("snb");
			
			$(function(){
				$(".on").parents('ul').slideDown();
			});	
			
			$(".submenu").click(function(){
				$(".submenu").not($(this)).children('ul').slideUp();
				$(this).children('ul').slideToggle();
			});
		</script>
<!-- //snb -->
<!-- contents -->
<div id="contents">
<!-- mnvisual - ÄÁÅÙÃ÷ Å¸ÀÌÆ² -->
<div class="mnvisual">
<!-- h2 - Å¸ÀÌÆ² -->
<!-- //h2 - Å¸ÀÌÆ² -->
<!-- location - ÁÖ¼Ò -->
<div id="location"> <a class="home" href="../261f58801c1da21d0b6f7021b30b648b">HOME</a> &gt; <a href="616feca8de871f8a1f1e040342b5d550">ABOUT MOHW</a> &gt; <span class="here">Press Release</span></div>
<!-- //location - ÁÖ¼Ò -->
</div>
<!-- //mnvisual - ÄÁÅÙÃ÷ Å¸ÀÌÆ² -->
<!-- content-area -->
<div class="content-area">
<!-- DB ¿¡¼­ contents µ¥ÀÌÅÍ¸¦ °¡Á®¿Í¼­ »Ñ·ÁÁØ´Ù. -->
<!-- board -->
<form action="ssg0111vw.jsp" method="post" name="fmView">
<input name="PAR_MENU_ID" type="hidden" value="1001"/>
<input name="MENU_ID" type="hidden" value="100111"/>
<input name="page" type="hidden" value="14"/>
<input name="CONT_SEQ" type="hidden" value="299419"/>
<input name="MENU_ID" type="hidden" value="100111"/>
<input name="FILE_SEQ" type="hidden" value=""/>
<input name="SEARCHKEY" type="hidden" value=""/>
<input name="SEARCHVALUE" type="hidden" value=""/>
<!-- table:view -->
<table class="view" summary="ABOUT MOHW &gt; Press Release detail.">
<caption>ABOUT MOHW &gt; Press Release</caption>
<colgroup>
<col width="12%"/><col width="38%"/><col width="12%"/><col width="38%"/>
</colgroup>
<tbody>
<tr>
<th scope="row">Subject</th>
<td colspan="3">Expensive Anticancer Drugs to be covered by Health Insurance</td>
</tr>
<tr>
<th scope="row">Date</th>
<td>2014-03-24</td>
<th scope="row">Hit</th>
<td>4017</td>
</tr>
<tr>
<th scope="row">Contents</th>
<td class="view" colspan="3"><p align="center" class="MsoNormal" style="margin: 0cm 0cm 13.25pt 18pt; word-break: keep-all; text-autospace: ideograph-numeric; text-align: center; mso-line-height-alt: 10.95pt; mso-pagination: widow-orphan">
<b style="mso-bidi-font-weight: normal"><u><span lang="EN-US" style="font-size: 12pt"><font color="#000000"><font face="¸¼Àº °íµñ">Expensive Anticancer Drugs to be covered by Health Insurance<o:p></o:p></font></font></span></u></b></p>
<p align="center" class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; text-align: center; mso-list: l0 level1 lfo1">
<font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">3<sup>rd</sup> Health Insurance Policy Review Board Held in 2014<o:p></o:p></font></font></span></font></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 5.25pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 5.25pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">The Ministry of Health and Welfare (Minister: Moon Hyung-pyo) held the 3<sup>rd</sup> Heath Insurance Policy Deliberation Committee (HIPDC) to deliberate and decide on covered drugs and upper limit amounts of covered drugs.<o:p></o:p></font></font></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 5.25pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ"><span style="mso-spacerun: yes">  </span><span style="mso-spacerun: yes"> </span><o:p></o:p></font></font></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 5.25pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<font size="2"><font color="#000000"><font face="¸¼Àº °íµñ"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><rectal span=""><span style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt">·<span lang="EN-US">colorectal Cancer &amp; Multiple Myeloma Treatment Drugs covered by Health Insurance (Risk-Sharing Scheme)&gt;<o:p></o:p></span></span></rectal></span></font></font></font></p>
<p>
<rectal span="">
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 5.25pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">With the introduction of risk-sharing scheme* intended to enhance insurance coverage of four critical illnesses, ‘Erbitux Injection’ used for the treatment of metastatic colorectal or rectal cancer and ‘Revlimid Capsules’ used to treat multiple myeloma will now be covered by health insurance.<span style="mso-spacerun: yes">  </span><o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 5.25pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ"><span style="mso-spacerun: yes"> </span><o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 7.1pt; vertical-align: baseline; word-break: keep-all; text-indent: -7.1pt; line-height: 180%; mso-char-indent-count: -.71">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">* Risk-Sharing Scheme is a risk-sharing agreement between pharmaceuticals and health insurers on drugs that were approved by FDA but whose efficacy and cost-effectiveness remain elusive. <span style="mso-spacerun: yes"> </span>This scheme is typically applied to expensive cancer drugs, and orphan drugs. <o:p></o:p></font></font></font></span></span></p>
<p>
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"> </span></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-right: medium none; border-top: medium none; border-left: medium none; border-bottom: medium none; border-collapse: collapse; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-border-insideh: .5pt solid windowtext; mso-border-insidev: .5pt solid windowtext">
<tbody>
<tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes">
<td style="border-right: windowtext 1pt solid; padding-right: 5.4pt; border-top: windowtext 1pt solid; padding-left: 5.4pt; padding-bottom: 0cm; border-left: windowtext 1pt solid; width: 461.2pt; padding-top: 0cm; border-bottom: windowtext 1pt solid; background-color: transparent; mso-border-alt: solid windowtext .5pt" valign="top" width="615">
<p align="center" class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%; text-align: center">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">[Patient Out-of-pocket Costs Reduction Cases ]<o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><span lang="EN-US" style="line-height: 180%; font-family: 'wingdings 2'; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt; mso-ascii-font-family: '¸¼Àº °íµñ'; mso-hansi-font-family: '¸¼Àº °íµñ'; mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><span style="mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'">™</span></span><font face="¸¼Àº °íµñ"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"> Erbitux Injection (colorectal</span><span style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt">·<span lang="EN-US">rectal cancer treatment)<o:p></o:p></span></span></font></font></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><font face="¸¼Àº °íµñ"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2">Monthly Patient Out-of-pocket Cost : approx. 4.5 million won </font></span><span style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2">→ <span lang="EN-US">approx. 230 thousand won with insurance coverage<span style="mso-spacerun: yes">  </span><span style="mso-spacerun: yes"> </span><o:p></o:p></span></font></span></font></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><span lang="EN-US" style="line-height: 180%; font-family: 'wingdings 2'; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt; mso-ascii-font-family: '¸¼Àº °íµñ'; mso-hansi-font-family: '¸¼Àº °íµñ'; mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><span style="mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'">™</span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="¸¼Àº °íµñ"> Revlimid Capsules (multiple myeloma drug) <o:p></o:p></font></span></font></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><font face="¸¼Àº °íµñ"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2">Monthly Patient Out-of-pocket Cost: approx. 6 million won </font></span><span style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2">→<span lang="EN-US"> approx. 300 thousand won with insurance coverage<o:p></o:p></span></font></span></font></font></span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">&lt; The Scope of Patient Out-of-Pocket Cost for Dental Implants &gt;<o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">As dental implants for seniors aged over 75 will be covered by health insurance beginning July 2014, the level of out-of-pocket for patients for covered dental implants will be 50% of the total cost incurred, as is the case with dentures. Upper limit of out-of-pocket cost for covered dental implants, however, will not be fixed. <o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">Other coverage details, such as scope and number of teeth to be covered will be finalized in May through public discussions and be applied beginning July as per the initial announcement. <span style="mso-spacerun: yes"> </span><o:p></o:p></font></font></span></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">&lt;2014 Four Critical Illness Coverage Enhancement Plan&gt;<o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">In accordance with the ‘Four Critical Illnesses Coverage Enhancement Plan’ unveiled on June 26, 2013, the Ministry of Health &amp; Welfare debriefed HIPDC about the key areas which will be covered intensively by health insurance in 21014.<o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">Approximately 90 medical items*, including expensive cancer drugs, image examination, such as MRI, and innovative treatments will either be newly covered or have their coverage expanded. In particular, the Ministry of Health &amp; Welfare stated that it plans to begin coverage for state-of-the-art surgical procedures and treatment materials earlier than previously planned (sometime after 2015).<o:p></o:p></font></font></span></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">* About 540 billion won of funding will be required to cover the cost.<o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 14.2pt; vertical-align: baseline; word-break: keep-all; text-indent: -14.2pt; line-height: 180%; mso-char-indent-count: -1.42">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; font-family: 'wingdings 2'; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt; mso-ascii-font-family: '¸¼Àº °íµñ'; mso-hansi-font-family: '¸¼Àº °íµñ'; mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><span style="mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><font size="2">j</font></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="¸¼Àº °íµñ" size="2"> Uncovered items, such as PET, MRI and optical CT, </font></span><span lang="EN-US" style="line-height: 180%; font-family: 'wingdings 2'; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt; mso-ascii-font-family: '¸¼Àº °íµñ'; mso-hansi-font-family: '¸¼Àº °íµñ'; mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><span style="mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><font size="2">k</font></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font face="¸¼Àº °íµñ" size="2"> items which the public strongly demanded insurance coverage for, such as breast reconstruction, and artificial vocal cord implants, and </font></span><span lang="EN-US" style="line-height: 180%; font-family: 'wingdings 2'; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt; mso-ascii-font-family: '¸¼Àº °íµñ'; mso-hansi-font-family: '¸¼Àº °íµñ'; mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><span style="mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><font size="2">l</font></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ"> items which enhance the quality of living are among the 90 items newly covered or with expanded coverage <o:p></o:p></font></font></span></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">Uncovered items whose cost-effectiveness is low but are strongly demanded by the public for insurance coverage will be covered but with higher ratio of patient out-of-pocket costs. (e.g. 50%~80%).<span style="mso-spacerun: yes">  </span><span style="mso-spacerun: yes">  </span><o:p></o:p></font></font></span></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">&lt; Policy Direction With Regard to Uncovered Items, such as Selected Treatment &gt; <o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ"><span style="mso-spacerun: yes"> </span>Ministry of Health &amp; Welfare explained to HIPDC its policy direction with regard to uncovered items, which it announced in its policy report to the President on February 11<sup>th</sup>, and discussed future plans. <o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">Patient out-of-pocket expenses for selected treatment will be reduced by 35% beginning the second half of this year and the current uncovered selected system will be abolished. <o:p></o:p></font></font></span></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">Four-bed wards will be covered by health insurance and the ratio of general wards will be raised.<o:p></o:p></font></font></span></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">After the completion of the pilot program for comprehensive nursing care, the Ministry will gradually expand nursing care services to other hospitals and begin to subsidize the cost through national healthcare insurance scheme. <o:p></o:p></font></font></span></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">To address side effects of medical system enhancement, such as overconcentration of patients in large hospitals, the Ministry will improve medical care delivery system and develop supplementary measures, such as relatively easing the burden of using small and medium sized hospitals. <o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">Details of insurance coverage will be finalized after further discussion at HIPDC. <o:p></o:p></font></font></span></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">&lt; Removing Rebated Drugs from the List of Covered Drugs&gt;<o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">In accordance with the National Healthcare Insurance Law Amendment, which limits insurance coverage for rebated drugs, the Ministry reported the subordinate regulations to HIPDC. <o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">The period of insurance coverage suspension will be determined in proportion to the rebate amounts, and when a pharmaceutical company is caught again for offering rebate for the same drug within five years after the suspension period for first time violation ends, the suspension period will be extended by additional two months, and for third time violation or when suspension period exceeds 12 months, the drug will no longer be covered by healthcare benefits.<span style="mso-spacerun: yes">  </span><o:p></o:p></font></font></span></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 7.1pt; vertical-align: baseline; word-break: keep-all; text-indent: -7.1pt; line-height: 180%; mso-char-indent-count: -.71">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">* First time violation:<span style="mso-spacerun: yes">  </span>warning for rebate amount up to 5 million won; 12 month suspension for rebate amount over 100 million won<o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 7.1pt; vertical-align: baseline; word-break: keep-all; line-height: 180%; mso-para-margin-top: 0cm; mso-para-margin-right: 0cm; mso-para-margin-bottom: .0001pt; mso-para-margin-left: .71gd">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">Second time violation: 2 months for rebate amount up to 5 million won or less, removed from covered drug list for rebate amount over 100 million won <o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; text-indent: 5pt; line-height: 180%; mso-char-indent-count: .5">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">Third time violation: removed from the covered drug list<span style="mso-spacerun: yes">  </span><o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">In case rebated drugs are shortage-prevention drugs, orphan drugs, or single source drugs, they will continue to be covered by insurance in order to ensure uninterrupted patient treatment, but 15~40% of the amount covered by health insurance will be imposed as penalty. <o:p></o:p></font></font></span></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><font face="¸¼Àº °íµñ">HIPDC also discussed how to run the Relative Value Administrative Planning Committee as well as the scope of medical care benefits for novel medical technologies. <o:p></o:p></font></font></font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">HIPDC decided to form the Relative Value Administrative Planning to discuss issues such as tackling the imbalance between medical departments and realignment of added clinical value system. <o:p></o:p></font></font></span></font></span></p>
<p>
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"> </span></p>
<table border="1" cellpadding="0" cellspacing="0" class="MsoNormalTable" style="border-right: medium none; border-top: medium none; border-left: medium none; border-bottom: medium none; border-collapse: collapse; mso-border-alt: solid windowtext .5pt; mso-yfti-tbllook: 1184; mso-padding-alt: 0cm 5.4pt 0cm 5.4pt; mso-border-insideh: .5pt solid windowtext; mso-border-insidev: .5pt solid windowtext">
<tbody>
<tr style="mso-yfti-irow: 0; mso-yfti-firstrow: yes; mso-yfti-lastrow: yes">
<td style="border-right: windowtext 1pt solid; padding-right: 5.4pt; border-top: windowtext 1pt solid; padding-left: 5.4pt; padding-bottom: 0cm; border-left: windowtext 1pt solid; width: 461.2pt; padding-top: 0cm; border-bottom: windowtext 1pt solid; background-color: transparent; mso-border-alt: solid windowtext .5pt" width="615">
<p class="MsoNormal" style="margin: 0cm 0cm 10pt 5.25pt; text-indent: 40pt; mso-char-indent-count: 4.0">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US"><font color="#000000" face="¸¼Àº °íµñ" size="2">&lt; <b style="mso-bidi-font-weight: normal">Relative Value Administrative Planning Committee Composition (Draft)</b>&gt;</font></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 10pt 5.25pt">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><span lang="EN-US" style="font-family: 'wingdings 2'; mso-ascii-font-family: '¸¼Àº °íµñ'; mso-hansi-font-family: '¸¼Àº °íµñ'; mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><span style="mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'">j</span></span><span lang="EN-US"><font face="¸¼Àº °íµñ"> <b style="mso-bidi-font-weight: normal">Medical service providers </b>(6 pax.): Korean Medical Association, Korean Dental Association, The Association of Korean Medicine, Korea Pharmaceutical Association, Korean Nurses Association</font></span></font></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 10pt 5.25pt">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><span lang="EN-US" style="font-family: 'wingdings 2'; mso-ascii-font-family: '¸¼Àº °íµñ'; mso-hansi-font-family: '¸¼Àº °íµñ'; mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><span style="mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'">k</span></span><span lang="EN-US"><font face="¸¼Àº °íµñ"> <b style="mso-bidi-font-weight: normal">Health Insurance Subscribers</b> (3 pax.): 3 experts recommended by HIPDC</font></span></font></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 10pt 5.25pt">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><span lang="EN-US" style="font-family: 'wingdings 2'; mso-ascii-font-family: '¸¼Àº °íµñ'; mso-hansi-font-family: '¸¼Àº °íµñ'; mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><span style="mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'">l</span></span><span lang="EN-US"><font face="¸¼Àº °íµñ"> <b style="mso-bidi-font-weight: normal">Representatives Upholding Public</b> <b style="mso-bidi-font-weight: normal">Interest</b> (4 pax.): 3 academics in related fields, one from Ministry of Health and Welfare</font></span></font></font></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 10pt 5.25pt">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font color="#000000"><span lang="EN-US" style="font-family: 'wingdings 2'; mso-ascii-font-family: '¸¼Àº °íµñ'; mso-hansi-font-family: '¸¼Àº °íµñ'; mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'"><span style="mso-char-type: symbol; mso-symbol-font-family: 'wingdings 2'">m</span></span><span lang="EN-US"><font face="¸¼Àº °íµñ"> Each from <b style="mso-bidi-font-weight: normal">Health Insurance Review Agency </b>and <b style="mso-bidi-font-weight: normal">National Health Insurance Corporation</b></font></span></font></font></span></p>
</td>
</tr>
</tbody>
</table>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt; vertical-align: baseline; word-break: keep-all; line-height: 180%">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><o:p><font color="#000000" face="¸¼Àº °íµñ" size="2"> </font></o:p></span></span></p>
<p class="MsoNormal" style="margin: 0cm 0cm 0pt 23.25pt; vertical-align: baseline; word-break: keep-all; text-indent: -18pt; line-height: 180%; mso-list: l0 level1 lfo1">
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font color="#000000"><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: '¸¼Àº °íµñ'; mso-font-kerning: 0pt"><span style="mso-list: ignore"><font face="¸¼Àº °íµñ" size="2">-</font><span style="font: 7pt 'times new roman'">       </span></span></span><span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><font size="2"><font face="¸¼Àº °íµñ">HIRDC decided to exclude five items* including vancomycin-resistant enterococci genotype test (real-time PCR) from medical care benefit coverage given their low cost-effectiveness. <o:p></o:p></font></font></span></font></span></p>
<p>
<span lang="EN-US" style="line-height: 180%; mso-bidi-font-size: 10.0pt; mso-bidi-font-family: ±¼¸²; mso-font-kerning: 0pt"><span lang="EN-US" style="font-size: 10pt; line-height: 115%; font-family: '¸¼Àº °íµñ'; mso-bidi-font-family: ±¼¸²; mso-ansi-language: en-us; mso-fareast-language: ko; mso-bidi-language: ar-sa"><font color="#000000">* Five items excluded from insurance coverage: Vancomycin-resistant enterococci genotype test (real-time PCR), Y chromosome microdeletion (multiplex PCR), non-invasive cardiac output monitoring based on bioreactance, enhanced external counterpulsation, and digital breast tomosynthesis</font></span></span></p>
</rectal></p></td>
</tr>
<tr>
<th scope="row">File</th>
<td colspan="3">
<p><img alt="" src="../../images/common/file/icon_doc.gif"/> <a href="../../../download.mohw.go.kr/front_new/modules/45d56541d7461a3624c43f83101a1772">[ENG][3.5]Expensive_Anticancer_Drugs_to_be_covered_by_Health_Insurance.doc (73 KB / Download : 476)</a></p>
</td>
</tr>
</tbody>
</table>
<!-- /table:view -->
<!-- ÇÏ´Ü ¹öÆ° ¿µ¿ª -->
<div class="btn btm">
<!--  ¿À¸¥ ÂÊ ¿µ¿ª ¹öÆ° -->
<a href="291c7b2c06ad0f481977e50fbd85795e"><img alt="list" class="right" src="../../images/eng/common/btn_list.gif"/></a>
<!--  /¿À¸¥ ÂÊ ¿µ¿ª ¹öÆ° -->
</div>
<!-- /ÇÏ´Ü ¹öÆ° ¿µ¿ª -->
</form>
<br/>
<br/>
<div class="view_list">
<form action="ssg0111ls.jsp" method="post" name="fmList">
<input name="PAR_MENU_ID" type="hidden" value="1001"/>
<input name="MENU_ID" type="hidden" value="100111"/>
<input name="page" type="hidden" value="14"/>
<input name="SEARCHKEY" type="hidden" value=""/>
<input name="SEARCHVALUE" type="hidden" value=""/>
<input name="CONT_SEQ" type="hidden" value=""/>
<!-- table head above list -->
<div id="tablehead">
<p>Total <strong>345</strong> Articles</p>
</div>
<!-- /table head above list -->
<table class="list" summary="Publication list.">
<caption>Publication</caption>
<colgroup>
<col width="8%"/><col width="60%"/>
<col width="16%"/><col width="8%"/><col width="8%"/>
</colgroup>
<thead>
<tr>
<th class="first" scope="col">No</th>
<th scope="col">Subject</th>
<th scope="col">Date</th>
<th scope="col">File</th>
<th scope="col">Hit</th>
</tr>
</thead>
<tbody>
<tr>
<td>215</td>
<td class="left"><a href="714174925d055a5fb88dbee02e3421dc">MERS Statistics (June 26)</a></td>
<td>2015-06-26</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>1574</td>
</tr>
<tr>
<td>214</td>
<td class="left"><a href="71cbeed3fd534aec08c616bd7da1f521">Press Release (June 25)</a></td>
<td>2015-06-26</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>1501</td>
</tr>
<tr>
<td>213</td>
<td class="left"><a href="833a8cabd890e05c2742195fb824925d">MERS Statistics (June 25)</a></td>
<td>2015-06-26</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>1409</td>
</tr>
<tr>
<td>212</td>
<td class="left"><a href="05ce7d1b97774e97b3ef5614a47bac15">Anshim (Safe) Hospitals (June 23)</a></td>
<td>2015-06-25</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>1602</td>
</tr>
<tr>
<td>211</td>
<td class="left"><a href="df3473b5298741443dcdf1bf0b952d7b">Press Release Summary (June 24)</a></td>
<td>2015-06-24</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>2236</td>
</tr>
<tr>
<td>210</td>
<td class="left"><a href="a4fa80cf2ee38e928d539ad802a5c544">236 ERs Run Selective Clinics to Deal With Suspect...</a></td>
<td>2015-06-24</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>1702</td>
</tr>
<tr>
<td>209</td>
<td class="left"><a href="863e21cf37a2be6c55480914dc7cc958">MERS Hotline Expands Services</a></td>
<td>2015-06-23</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>1696</td>
</tr>
<tr>
<td>208</td>
<td class="left"><a href="d0477557edb13243f65dbf74ef40a94d">All-out Effort to Contain MERS</a></td>
<td>2015-06-23</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>1616</td>
</tr>
<tr>
<td>207</td>
<td class="left"><a href="65a09eb80dc8b3c252bbe6e4b06acbfd">Full Disclosure of Medical Facilities Exposed to M...</a></td>
<td>2015-06-23</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>1723</td>
</tr>
<tr>
<td>206</td>
<td class="left"><a href="cb9c2c999d823640ba5395a3b161f17d">MERS Statistics (June 23)</a></td>
<td>2015-06-23</td>
<td><img alt="file" src="../../images/eng/common/icon_file.gif"/></td>
<td>2013</td>
</tr>
</tbody>
</table>
<!-- /table:list -->
<!-- paging -->
<!-- paging -->
<div id="paging">
<a class="btn" href="ebfb6bc3f850eb20122e1021c6e4c0d1"><img alt="first page" src="../../images/eng/common/btn_firstpage.gif"/></a>
<a class="btn" href="ffdc4366d327476f2a2bdd61bea75d3f"><img alt="pre page" src="../../images/eng/common/btn_prepage.gif"/></a>
<a href="b5ac7ead72941feddd2152cd97408423" title="11page">11</a> 

				<a href="43305223367df6986d635c77763975b3" title="12page">12</a> 

				<a href="2711dbddb6de0a13625580768c3557fa" title="13page">13</a> 

				<span title="present">14</span> 

				<a href="69279edea38f89c531ee92dcc558f429" title="15page">15</a> 

				<a href="3d5e6982b8cfbd3ae4834a4e77e21144" title="16page">16</a> 

				<a href="32fde42f13158f6b4f430ac227830ad3" title="17page">17</a> 

				<a href="e9a17658ff68b1011b3bf38b014eea17" title="18page">18</a> 

				<a href="3fbff7a5c45a170ce3270ba839fff4fb" title="19page">19</a> 

				<a href="095823f82b64fc9c0ab92d552e48e0b3" title="20page">20</a> 

				<a class="btn" href="6c8765ade6af448afd7277d09046c33a"><img alt="next page" src="../../images/eng/common/btn_nextpage.gif"/></a>
<a class="btn" href="2d7e34ab1d5e2a71b1530de73fd24299"><img alt="last page" src="../../images/eng/common/btn_lastpage.gif"/></a>
</div>
<!-- /paging -->
<!-- /paging -->
</form>
<!-- DB ¿¡¼­ contents µ¥ÀÌÅÍ¸¦ °¡Á®¿Í¼­ »Ñ·ÁÁØ´Ù. -->
</div>
</div>
<!-- /contents -->
</div>
</div>
<!-- footer -->
<!-- footer -->
<div id="footer">
<div class="foot">
<p class="flogo"><img alt="ministry of health and welfare" src="../../images/eng/common/flogo.gif"/></p>
<div class="finfo">
<address><img alt="13, Doum 4-ro, Sejong, (30113) Korea ¤ÓCALL CENTER 82-129" src="../../images/eng/common/foot_address.gif"/></address>
<p class="copyright"><img alt="Copyright(C) By MOHW. All rights reserved." src="../../images/eng/common/foot_copyright.gif"/></p>
</div>
<!-- ÀÏÀÏ¹æ¹®ÀÚ¼ö Ãß°¡ -->
<p class="visits">Daily visits : <strong>198</strong></p>
<!--// ÀÏÀÏ¹æ¹®ÀÚ¼ö Ãß°¡ -->
</div>
</div>
<!-- //footer -->
</div>
<div id="returntotop"><a href="#skip-navi">go to the top</a></div>
<script type="text/javascript">
//<![CDATA[
function jsOpenSite(formEl) {	
	var errorMessage = null;
	var objFocus = null;
	if (formEl.sitelink.value.length == 0) {
		errorMessage = "please! select a site to move!";
		objFocus = formEl.sitelink;
	} 
	if(errorMessage != null) {
		alert(errorMessage);
		objFocus.focus();
		return false;
	}
	return true;
}
//]]>	
</script>
<script type="text/javascript">
  (function(i,s,o,g,r,a,m){i['GoogleAnalyticsObject']=r;i[r]=i[r]||function(){
  (i[r].q=i[r].q||[]).push(arguments)},i[r].l=1*new Date();a=s.createElement(o),
  m=s.getElementsByTagName(o)[0];a.async=1;a.src=g;m.parentNode.insertBefore(a,m)
  })(window,document,'script','https://www.google-analytics.com/analytics.js','ga');

  ga('create', 'UA-101800795-1', 'auto');
  ga('send', 'pageview');

</script>
<!-- /footer -->
</div>
</body>
</html>